Tensor based morphometry (TBM) was applied to determine the atrophy of deep gray matter (DGM) structures in 88 relapsing multiple sclerosis (MS) patients. For group analysis of atrophy, an unbiased atlas was constructed from 20 normal brains. The MS brain images were co-registered with the unbiased atlas using a symmetric inverse consistent nonlinear registration. These studies demonstrate significant atrophy of thalamus, caudate nucleus, and putamen even at a modest clinical disability, as assessed by the expanded disability status score (EDSS). A significant correlation between atrophy and EDSS was observed for different DGM structures: (thalamus: r=-0.51, p=3.85 x 10(-7); caudate nucleus: r=-0.43, p=2.35 x 10(-5); putamen: r=-0.36, p=6.1...
Background: In multiple sclerosis (MS), demyelination and neuro-axonal loss occur in the brain ...
Background and Objectives: There is currently no consensus about the extent of gray matter (GM) atro...
In multiple sclerosis (MS), gray matter (GM) atrophy progresses in a non-random manner, possibly in ...
Tensor based morphometry (TBM) was applied to determine the atrophy of deep gray matter (DGM) struct...
Deep gray matter involvement is a consistent feature in multiple sclerosis. The aim of this study wa...
peer reviewedDespite robust postmortem evidence and potential clinical importance of gray matter (GM...
International audienceThe existence of grey matter (GM) atrophy right after the first clinical event...
Objectives. Grey matter (GM) involvement is clinically relevant in multiple sclerosis (MS). Using so...
Background Brain atrophy is a well-accepted imaging biomarker of multiple sclerosis (MS) that partia...
Background: Source-based morphometry (SBM) was recently used for non-random “patterns” of gray matte...
Objective: Cortical pathology, periventricular demyelination and lesion formation in multiple scler...
Objectives: To investigate spatial patterns of gray matter (GM) atrophy and their association with d...
Background: In MS, the relationship between lesions within cerebral white matter (WM) and atrophy wi...
Background The extent and clinical relevance of grey matter (GM) pathology in multiple sclerosis (MS...
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
Background: In multiple sclerosis (MS), demyelination and neuro-axonal loss occur in the brain ...
Background and Objectives: There is currently no consensus about the extent of gray matter (GM) atro...
In multiple sclerosis (MS), gray matter (GM) atrophy progresses in a non-random manner, possibly in ...
Tensor based morphometry (TBM) was applied to determine the atrophy of deep gray matter (DGM) struct...
Deep gray matter involvement is a consistent feature in multiple sclerosis. The aim of this study wa...
peer reviewedDespite robust postmortem evidence and potential clinical importance of gray matter (GM...
International audienceThe existence of grey matter (GM) atrophy right after the first clinical event...
Objectives. Grey matter (GM) involvement is clinically relevant in multiple sclerosis (MS). Using so...
Background Brain atrophy is a well-accepted imaging biomarker of multiple sclerosis (MS) that partia...
Background: Source-based morphometry (SBM) was recently used for non-random “patterns” of gray matte...
Objective: Cortical pathology, periventricular demyelination and lesion formation in multiple scler...
Objectives: To investigate spatial patterns of gray matter (GM) atrophy and their association with d...
Background: In MS, the relationship between lesions within cerebral white matter (WM) and atrophy wi...
Background The extent and clinical relevance of grey matter (GM) pathology in multiple sclerosis (MS...
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
Background: In multiple sclerosis (MS), demyelination and neuro-axonal loss occur in the brain ...
Background and Objectives: There is currently no consensus about the extent of gray matter (GM) atro...
In multiple sclerosis (MS), gray matter (GM) atrophy progresses in a non-random manner, possibly in ...